TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21953653

Group type: EXPERIMENTAL
Intervention: Web-based training program; 60-minute interactive session supported by a clinical guide.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no training).
Number of subjects: 70
Study: 18173581

Group type: EXPERIMENTAL
Intervention: Acupressure and interactive multimedia intervention for visual health (15 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 17181922

Group type: EXPERIMENTAL
Intervention: Interferential currents (IFT) administered for 10 minutes daily for 5 days per week for two weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Horizontal therapy (HT) administered for 40 minutes daily for 5 days per week for two weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham HT administered for 40 minutes daily for 5 days per week for two weeks
Number of subjects: 120
Study: 14572947

Group type: EXPERIMENTAL
Intervention: Specific preoperative information
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine preoperative information
Number of subjects: 60
Study: 10937313

Group type: EXPERIMENTAL
Intervention: Anatomically detailed dolls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genital examination
Number of subjects: 0

Group type: COMPARATOR
Intervention: No genital examination
Number of subjects: 0
Study: 8738112

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (FO, 22 ml daily, containing 4.6 g of n‐3 fatty acids)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Gemfibrozil (G, 900 mg daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (FO, 22 ml daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Neither FO nor G
Number of subjects: 10
Study: 1568520

Group type: EXPERIMENTAL
Intervention: 500 mg O‐(beta‐hydroxyethyl)rutosides orally twice daily
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 3901421

Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGI2) administered at a rate of 2.5-5.0 ng/kg/min
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (glycine buffer)
Number of subjects: 26
Study: 30351169

Group type: EXPERIMENTAL
Intervention: Breastfeeding education video
Number of subjects: 816

Group type: COMPARATOR
Intervention: Prenatal nutrition video
Number of subjects: 816
Study: 27286693

Group type: EXPERIMENTAL
Intervention: Gluten Free Diet (GFD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular Diet (RD)
Number of subjects: 80
Study: 24913683

Group type: EXPERIMENTAL
Intervention: Decision aid (interactive CD-ROM)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Regular information from the surgeon
Number of subjects: 178
Study: 23145404

Group type: EXPERIMENTAL
Intervention: Case conferences
Number of subjects: 17
Study: 20521882

Group type: EXPERIMENTAL
Intervention: +1.00 D reading addition
Number of subjects: 22

Group type: COMPARATOR
Intervention: +2.00 D reading addition
Number of subjects: 22
Study: 18520448

Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (live, oral)
Number of subjects: 5098

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5098
Study: 15932357

Group type: EXPERIMENTAL
Intervention: Self-perceived physical status at homecoming and at 12 months after GBS onset
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Self-perceived impact of GBS on daily life and social well-being
Number of subjects: 90
Study: 14580131

Group type: EXPERIMENTAL
Intervention: BTX‐A
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: BTX‐A plus casting
Number of subjects: 10
Study: 10963018

Group type: EXPERIMENTAL
Intervention: Metaphonologically (MET) therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Articulation‐based (ART) therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (normally speaking children)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ART therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: MET therapy
Number of subjects: 61
Study: 8855091

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 600 mg/day for 20 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 20 days
Number of subjects: 16
Study: 1595916

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with plain bupivacaine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with plain bupivacaine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no surgery or anesthesia)
Number of subjects: 22
Study: 6091476

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g preoperative dose, placebo at 8 and 16 hours later)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Cefazolin (three 1 g doses over 16 hours)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 127

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Ceftriaxone and Cefazolin
Number of subjects: 127
Study: 31370809

Group type: EXPERIMENTAL
Intervention: 1 μg paricalcitol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 μg paricalcitol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29017972

Group type: EXPERIMENTAL
Intervention: Spirometry reference equations for men
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Spirometry reference equations for women
Number of subjects: 407

Group type: COMPARATOR
Intervention: Comparison of spirometric values with lowland population
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Age and height as predictors
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Linear decline of FVC and FEV1 with age
Number of subjects: 407
Study: 26325514

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2 to 0.7 μg/kg/h)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Remifentanil (0.08 to 0.15 μg/kg/min)
Number of subjects: 139
Study: 23722111

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) with an IMT load
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (negligible inspiratory resistance)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no IMT device or soccer training)
Number of subjects: 31
Study: 22348112

Group type: EXPERIMENTAL
Intervention: Full personalized normative feedback intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial feedback (without norms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 0
Study: 20145556

Group type: EXPERIMENTAL
Intervention: Moderate static stretching (SS) for knee flexors, 3-minute protocol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control condition (sitting for 10 minutes)
Number of subjects: 29
Study: 18056490

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (20 mL of 0.5% bupivacaine) along with standard pain management
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard pain management alone (typically intravenous narcotics)
Number of subjects: 54
Study: 15749490

Group type: EXPERIMENTAL
Intervention: Sperm treatment with exogenous PAF (10(‐7) mol/L) in sperm-washing medium, direct swim-up technique, maximum of six IUI cycles
Number of subjects: 52

Group type: COMPARATOR
Intervention: Direct swim-up technique without PAF treatment
Number of subjects: 52
Study: 12131185

Group type: EXPERIMENTAL
Intervention: IL-2 plus HAART (9 megaunits daily for 5 days in 6-week intervals for a total of eight cycles)
Number of subjects: 56

Group type: COMPARATOR
Intervention: HAART alone (stavudine, lamivudine, nelfinavir, saquinavir)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: IL-2 plus HAART
Number of subjects: 56
Study: 11908371

Group type: EXPERIMENTAL
Intervention: Colgate Actibrush battery‐powered toothbrush
Number of subjects: 61

Group type: COMPARATOR
Intervention: CrossAction Toothbrush
Number of subjects: 61
Study: 8961775

Group type: EXPERIMENTAL
Intervention: 20 mg/day selegiline
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 mg/day selegiline
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1553901

Group type: EXPERIMENTAL
Intervention: Indicine N-oxide at 2,000 mg/m2/day for 5 consecutive days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indicine N-oxide at 2,500 mg/m2/day for 5 consecutive days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indicine N-oxide
Number of subjects: 46
Study: 3964332

Group type: EXPERIMENTAL
Intervention: Preparation A (hard gelatine capsule with pellets)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Preparation B (soft gelatine capsule with liquid nifedipine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Preparation C (retard-tablet)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple dosing of nifedipine
Number of subjects: 12
Study: 31373068

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (Btx type B)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (Btx type B) (open label after placebo)
Number of subjects: 8
Study: 29384243

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: DASH diet with urine albumin excretion ≥7 mg/d
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: DASH diet with urine albumin excretion <7 mg/d
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Black race
Number of subjects: 202
Study: 26774708

Group type: EXPERIMENTAL
Intervention: Bilamellar tarsal rotation (BLTR) surgery
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Posterior lamellar tarsal rotation (PLTR) surgery
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Comparison of BLTR vs PLTR
Number of subjects: 1000
Study: 24670332

Group type: EXPERIMENTAL
Intervention: Asymptomatic vibration-exposed workers
Number of subjects: 31

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 31
Study: 22996849

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections of local anesthetic (lidocaine 0.5%)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with 0.5% lidocaine mixed with 1 mL of steroid (6 mg non-particulate betamethasone)
Number of subjects: 100
Study: 20577774

Group type: EXPERIMENTAL
Intervention: Short-pulsed 532 nm Medlite IV laser (10 ns, 1 J/cm²)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Long-pulsed 532 nm Aura laser (10 ms, 1 J/cm²)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 17
Study: 17921369

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (65% carbohydrate, 13% protein, 22% fat)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (48% carbohydrate, 19% protein, 33% fat)
Number of subjects: 100
Study: 16126058

Group type: EXPERIMENTAL
Intervention: Long-term transfusion (CTX)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard care (STC)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 94
Study: 12209526

Group type: EXPERIMENTAL
Intervention: Celecoxib (100 mg, 200 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 60
Study: 10074879

Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 1
Study: 7747322

Group type: EXPERIMENTAL
Intervention: Ivermectin (200 or 400 micrograms/kg)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC, 6 mg/kg)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Combination of ivermectin (20 micrograms/kg) followed 4 d later by DEC (6 mg/kg)
Number of subjects: 67
Study: 2153393

Group type: EXPERIMENTAL
Intervention: Chemotherapy (cyclophosphamide 1 g m‐2 i.v. day 1, vincristine 2 mg i.v. day 1, etoposide 100 mg tds p.o. days 1‐3, repeated every 21 days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 19
Study: 28986814

Group type: EXPERIMENTAL
Intervention: Shen-Fu Injection (SFI), 100 mL intravenously every 12 h
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (conventional treatment including volume resuscitation, antibiotics, and vasoactive drugs)
Number of subjects: 65
Study: 28098515

Group type: EXPERIMENTAL
Intervention: Ezetimibe (EZ) 10 mg/day
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Plant Sterol (PS) 2 g/day
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ezetimibe + Plant Sterol (EZ+PS) 10 mg/day + 2 g/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (CT) group on same statin therapy
Number of subjects: 41
Study: 26125572

Group type: EXPERIMENTAL
Intervention: Back massage (BM) intervention for 5 consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 60
Study: 23613027

Group type: EXPERIMENTAL
Intervention: Lay health worker (LHW) intervention
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study: 22310864

Group type: EXPERIMENTAL
Intervention: Interactive pictorial education plus information booklet
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Education only with information booklet
Number of subjects: 136

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 136
Study: 19185647

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin for 1 year
Number of subjects: 1816

Group type: COMPARATOR
Intervention: Placebo plus aspirin for 1 year
Number of subjects: 1816
Study: 18036086

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 19
Study: 15027183

Group type: EXPERIMENTAL
Intervention: Psychotherapy group (148 cases)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (110 cases)
Number of subjects: 258
Study: 11883256

Group type: EXPERIMENTAL
Intervention: Anthocyanins
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (healthy males)
Number of subjects: 38
Study: 9590187

Group type: EXPERIMENTAL
Intervention: ABLC (5 mg/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AmB (0.6 to 1 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABLC
Number of subjects: 0
Study: 8147064

Group type: EXPERIMENTAL
Intervention: One balloon inflation (group A, n = 167)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Three balloon inflations (group B, n = 168)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Three balloon inflations (group B1, n = 111)
Number of subjects: 300

Group type: COMPARATOR
Intervention: One balloon inflation (group A1, n = 70)
Number of subjects: 300
Study: 3049485

Group type: EXPERIMENTAL
Intervention: 100 mg of naproxen sodium
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 200 mg of naproxen sodium
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 54
Study: 29636047

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 60
Study: 27912986

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4CMenB and MenACWY-CRM vaccines
Number of subjects: 0
Study: 26882604

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Qingre Huashi Recipe (YHQHR), twice per day for 6 successive weeks, in addition to standard triple therapy.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard triple therapy alone (control group) plus omeprazole enteric coated tablet, 20 mg once per day for 4 weeks.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: YHQHR combined with standard triple therapy.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard triple therapy alone (control group).
Number of subjects: 80
Study: 23042930

Group type: EXPERIMENTAL
Intervention: 3D-FLAIR
Number of subjects: 37

Group type: COMPARATOR
Intervention: 3D-DIR
Number of subjects: 37

Group type: COMPARATOR
Intervention: 2D-T2WI
Number of subjects: 37

Group type: COMPARATOR
Intervention: 3D-T1WI
Number of subjects: 37
Study: 19960351

Group type: EXPERIMENTAL
Intervention: Aquatic exercise training using water-resistance equipment (90 min, 3 times per week for 8 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aquatic exercise training using water-resistance equipment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-resistance group (without water-resistance equipment)
Number of subjects: 20
Study: 19001024

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 42418

Group type: EXPERIMENTAL
Intervention: Chlorthalidone/amlodipine/lisinopril
Number of subjects: 42418

Group type: COMPARATOR
Intervention: Chlorthalidone/doxazosin
Number of subjects: 42418
Study: 17000226

Group type: EXPERIMENTAL
Intervention: Controlled release (CR)-melatonin 2 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 14666011

Group type: EXPERIMENTAL
Intervention: Circulatory arrest
Number of subjects: 155

Group type: COMPARATOR
Intervention: Low-flow bypass
Number of subjects: 155
Study: 11200306

Group type: EXPERIMENTAL
Intervention: Unopposed conjugated estrogens (CEE)
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: CEE plus continuous medroxyprogesterone (MPA)
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: CEE plus cyclical MPA
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: CEE plus cyclical micronised progesterone
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: All drug treatment groups
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Active treatment groups
Number of subjects: 875

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 875
Study: 8800590

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Naloxone plus vasopressin (AVP)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Naloxone plus alprazolam
Number of subjects: 7
Study: 1629380

Group type: EXPERIMENTAL
Intervention: Trazodone, mean daily dose 235 +/- 10 mg, 10 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo, 10 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Clomipramine and fluoxetine
Number of subjects: 21
Study: 6380301

Group type: EXPERIMENTAL
Intervention: Low calcium diet (300 mg calcium/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low sodium diet (2 gm sodium/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low calcium diet plus hydrochlorthiazide (25 mg twice a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Regular hospital diet
Number of subjects: 10
Study: 31904890

Group type: EXPERIMENTAL
Intervention: Smartphone-based care (SC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional care (CC)
Number of subjects: 40
Study: 29882811

Group type: EXPERIMENTAL
Intervention: High-Energy Breakfast (HE-BF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low-Energy Breakfast (LE-BF)
Number of subjects: 13
Study: 26343747

Group type: EXPERIMENTAL
Intervention: Sham SM (5% of pain pressure threshold)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-pressure SM (40% of pain pressure threshold)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-pressure SM (80% of pain pressure threshold)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no touch)
Number of subjects: 32
Study: 24154834

Group type: EXPERIMENTAL
Intervention: Automated email notification system
Number of subjects: 441
Study: 22285555

Group type: EXPERIMENTAL
Intervention: Session R (emotionally neutral task)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Session T (moderately threatening task)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Session T (ineffective T: iT subsample, n=15)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Comparison of HR and HRV between sessions and groups
Number of subjects: 81
Study: 20354807

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG)
Number of subjects: 267
Study: 18388340

Group type: EXPERIMENTAL
Intervention: sarpogrelate (100 mg TID)
Number of subjects: 1510

Group type: COMPARATOR
Intervention: aspirin (81 mg/d)
Number of subjects: 1510
Study: 15807810

Group type: EXPERIMENTAL
Intervention: Cutometer standard R-parameters and new area parameters (R3, R4, R9, F2, F3)
Number of subjects: 40
Study: 12955196

Group type: EXPERIMENTAL
Intervention: Elbow synovectomy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Synovectomy with radial head resection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups (synovectomy and synovectomy with radial head resection)
Number of subjects: 120
Study: 10394512

Group type: EXPERIMENTAL
Intervention: Defecography
Number of subjects: 125

Group type: COMPARATOR
Intervention: Clinical examination
Number of subjects: 125
Study: 8679834

Group type: EXPERIMENTAL
Intervention: Parenteral S-adenosylmethionine (SAMe)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 1726758

Group type: EXPERIMENTAL
Intervention: Isoprinosine and acyclovir (joint application)
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Acyclovir alone
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Isoprinosine only
Number of subjects: 636

Group type: COMPARATOR
Intervention: Palliative treatment only
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Palliative and isoprinosine treatment
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Palliative and acyclovir treatment
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: All treatments (palliative, isoprinosine, and acyclovir)
Number of subjects: 636
Study: 6219903

Group type: EXPERIMENTAL
Intervention: Combination tablet containing orphenadrine citrate and paracetamol ('Norgesic')
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 0
Study: 30955572

Group type: EXPERIMENTAL
Intervention: Nasal high-frequency oscillatory ventilation (NHFOV)
Number of subjects: 206

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 206
Study: 28353116

Group type: EXPERIMENTAL
Intervention: 40-unit RCI twice a week
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80-unit RCI twice a week
Number of subjects: 16

Group type: COMPARATOR
Intervention: 80-unit RCI
Number of subjects: 16

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16